Eli Lilly experienced an 11% share price increase over the past month, largely influenced by the affirmation of a $1.50 per share dividend declared for the second quarter. The announcement of Q1 ...

All was not positive on the GLP-1 drug front, though. On the day of Eli Lilly's earnings report, CVS Health announced that its pharmacy benefit manager (PBM) unit Caremark would make rival weight ...

Eli Lilly announced a successful Phase 3 clinical trial of its new GLP-1 weight loss drug, orforglipron, which comes in pill form -- not an injection. This first trial showed weight loss of 7.9% ...

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Former Giants quarterback Eli Manning, who inevitably will join Strahan in Canton, has a separate bid in the works. He reportedly had “preliminary conversations” about joining Strahan’s group, but Eli ...

Eli Manning is reportedly taking a page out of Tom Brady's playbook, considering a move from former NFL quarterback to future NFL owner. The New York Giants great now has competition for a ...

Eli Lilly (NYSE:LLY) shares climbed ~14% in the premarket on Thursday after the company said its oral GLP-1 receptor agonist orforglipron reached the main goal in a Phase 3 trial for adults with ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade deals and warned of the harmful effects retaliatory tariffs could have on American exporters like Eli Lilly.

Tom Brady takes a new shot in his two-decade war with Eli Manning: Trading card store sabotage Strahan entered the NFL as the 40th overall pick in the 1993 draft and spent 15 seasons with the Giants.

Retired New York Giants quarterback Eli Manning wants to be a Giant for life. Not that he has to worry about losing a spot in the franchise's good graces after helping to deliver two of the ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial. "We are ...